Tag: biotechnology
-
Modern Findings That Should Change How You Approach Your Health
Some of the most exciting findings of the modern day relate to discoveries in the workings of the human body, and the implications of these for our journeys towards health and fitness.
-
Genetic Repair Company Starts-Up, Gains $87 Million
A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA.
-
Crispr Deployed to Correct Inherited Vision Disorder
Researchers at Columbia University developed and tested in lab mice a technique using the genome editing technology Crispr with gene replacement therapy to correct the inherited eye disease retinitis pigmentosa.
-
University, Industry Labs Partner on Bioprinted Tissue
A joint project between Indiana University and the company Lung Biotechnology is investigating three-dimensional bioprinting to produce animal tissue for research on organ transplantation, and eventually for transplants themselves.
-
Genentech Gains Microbe Drug Discovery Tech in $1B Deal
Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil.
-
Univ. Spinoff Qualifies for NIH Clinical Program
An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials.
-
3-D Models Devised to Simulate Patients’ Tumors
A university lab is teaming up with a local biotechnology company to develop realistic models of tumors from individual cancer patients, enabling more personalized treatment options.
-
Trial Underway Testing Universal Flu Vaccine
A clinical trial is recruiting participants to test a vaccine to protect against a variety of influenza strains, instead of today’s vaccines designed to prevent infections from specific strains expected in a given year.
-
New Cell Therapy Company Raises $58.5M in Early Funds
A start-up enterprise is discovering therapies to address a variety of disorders that result from faulty cell degradation processes known as autophagy, which when functioning normally contribute to cell health.
-
Cellectis, Wyss Inst. Partner on Recoding Human Genome
A bioengineering center at Harvard University and a biotechnology company are creating a process for genetically editing human cell lines to produce virus-resistant synthetic proteins for research and therapies.